Jeffrey Cooper MS, OD, FAAO
Professor Emeritus SUNY College of Optometry, Private Practice 539 Park Ave, NY, NYDr. Jeffrey Cooper is Professor Emeritus at the State University of New York, College of Optometry. He graduated from Pennsylvania College of Optometry in 1971, later that year he completed a special post-graduate training program in Vision Therapy at SUNY College of Optometry. He served as the assistant chief of the Vision Therapy Services from 1972-1978. Dr. Cooper received a Masters of Science in physiological optics. He has authored over 60 research papers that have appeared in numerous prestigious ophthalmological and optometric journals. Currently, he is on the editorial board of Binocular Vision and Eye Muscle Surgery and the Journal of Behavioral Optometry. He is a reviewer for numerous professional publications.
Dr. Cooper, under the auspices of Bausch and Lomb, served as a consultant to the USA Olympic Team. He has provided peer review for research grants submitted to the National Institute of Health/National Eye Institute and was the PI on two large NEI clinical trials. Dr. Cooper presently teaches in the residency program – strabismus and amblyopia. He developed both the Computer Orthopter and the HTS therapy systems. Both of these treatment systems are used by more than 6,000 optometrists and ophthalmologists worldwide. He maintains practices in both Manhattan and Brooklyn.
Recent Contributions to PracticeUpdate:
- Long-Term Efficacy of Low-Concentration Atropine for Myopia Progression
- Effectiveness of Office-Based Vergence and Anti-Suppression Therapy for the Treatment of Small-to-Moderate Angle Intermittent Exotropia
- Effect of Low-Concentration Atropine Eyedrops Prophylactic Use on the Incidence of Myopia in Children
- Efficacy of Repeated Low-Level Red-Light Therapy for Controlling Myopia Progression in Children
- Pediatric Myopia Progression and Stabilization With Single-Vision Lenses
- Bilateral Occlusion Reduces Ocular Deviation in Exotropia
- Complications of Myopia
- Efficacy of Atropine 0.01% for the Treatment of Childhood Myopia
- Low-Concentration Atropine for Myopia Progression
- Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2